Colgate-Palmolive (CL) Reports In-Line Q2 EPS
Get Alerts CL Hot Sheet
Price: $88.41 -0.41%
EPS Growth %: +2.2%
Financial Fact:
Earnings per common share, basic (in dollars per share): 0.79
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +2.2%
Financial Fact:
Earnings per common share, basic (in dollars per share): 0.79
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Colgate-Palmolive (NYSE: CL) reported Q2 EPS of $0.80, in-line with the analyst estimate of $0.80. Revenue for the quarter came in at $4.26 billion versus the consensus estimate of $4.24 billion.
Full Year 2021 Guidance:
Based on current spot rates:
- The Company still expects net sales to be up 4% to 7% including a low-single-digit benefit from foreign exchange.
- The Company still expects organic sales to be up within its long-term targeted range of 3% to 5%.
- On a GAAP basis, the Company now expects a decline in gross profit margin, increased advertising investment and earnings-per-share growth at the lower end of its low to mid-single-digit range.
- On a non-GAAP (Base Business) basis, the Company now expects a decline in gross profit margin, increased advertising investment and earnings-per-share growth at the lower end of its mid to high-single-digit range.
For earnings history and earnings-related data on Colgate-Palmolive (CL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- First Hydrogen signs deal to acquire 60% stake in robotics IP firm
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share